MVMichael J. Veness

Michael J. Veness

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Michael J. Veness has a total of 27 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Quality of life assessment in patients treated for metastatic cutaneous squamous cell carcinoma of the head and neck

    by A Y Wang, C E Palme, J T Wang, G J Morgan, V Gebski, J Gilchrist, M J Veness

    Background:Treatment for metastatic cutaneous head and neck squamous cell carcinoma is usually multimodal and associated with morbidity. This study aimed to evaluate the impact of treatment on patients' quality of life.Method:Cross-sectional survey of 42 patients (35 men, 7 women) at least 6 months after metastatic cutaneous head and neck squamous cell carcinoma treatment, using two standardised quality of life questionnaires: the Functional Assessment of Cancer Therapy – Head and Neck questionnaire and the Facial Disability Index, with statistical analysis to identify potential predictors of outcome.Results:Female gender correlated with significantly lower Facial Disability Index physical function scores (p = 0.017). Alcohol consumption correlated with significantly better scores for Functional Assessment social well-being (p = 0.016), general total score (p = 0.041) and overall total score (p = 0.033), and for Facial Disability Index physical function (p = 0.034). Marital status, education, employment, chemotherapy, time from last treatment, parotidectomy and facial nerve sacrifice did not affect quality of life. The commonest patient complaints were dry mouth (76 per cent), altered voice quality and strength (55 per cent), and physical appearance (45 per cent).Conclusion:Female gender predicts worse quality of life, while alcohol consumption (versus none) predicted for better quality of life.


  • In patients with metastatic cutaneous head and neck squamous cell carcinoma to cervical lymph nodes, the extent of neck dissection does not influence outcome

    by J T Wang, C E Palme, A Y Wang, G J Morgan, V Gebski, M J Veness

    Background: This study aimed to compare recurrence and survival in patients undergoing either selective neck dissection or modified radical neck dissection to treat metastatic cutaneous head and neck squamous cell carcinoma to the cervical lymph nodes (levels I–V) only.Methods: Twenty-eight year, retrospective analysis of a prospectively maintained database from a tertiary referral hospital, with a minimum follow up of two years.Results: There were 122 eligible patients: 96 males (79 per cent) and 26 (21 per cent) females (median age, 66 years). Sixty-six patients (54 per cent) underwent selective neck dissection and 56 (46 per cent) modified radical neck dissection. The former patients had a lower rate of regional recurrence compared with the latter (17 vs 23 per cent, respectively). There was no significant difference in five-year overall survival (61 vs 57 per cent, respectively) or five-year disease-free survival (74 vs 60 per cent, respectively), comparing the two groups. Overall survival and disease-free survival were significantly improved by the addition of adjuvant radiotherapy.Conclusion: We found no difference in outcome in patients undergoing selective versus modified radical neck dissection. Adjuvant radiotherapy significantly improved outcome.


  • Predictors of outcome in patients with metastatic cutaneous head and neck squamous cell carcinoma involving cervical lymph nodes: Improved survival with the addition of adjuvant radiotherapy

    by Jeffrey T. Wang, Carsten E. Palme, Gary J. Morgan, Val Gebski, Allen Y. Wang, Michael J. Veness

    Background: The purpose of this study was to compare the outcome of surgery against surgery plus radiotherapy in patients with metastatic cutaneous head and neck squamous cell carcinoma (HNSCC) to cervical nodes.Methods: We conducted a 28‐year retrospective analysis of 122 patients whom were treated for metastatic cutaneous HNSCC involving the cervical nodes (levels I–V).Results: After surgery alone, 11 patients (55%) developed recurrence compared with 23 patients (23%) after surgery plus radiotherapy. On multivariate analysis, the following variables were significantly associated with disease‐free survival (DFS): immunosuppression (p = .002), treatment modality (p < .001), extracapsular spread (p = .009), and pathological nodal stage (p = .04). Patients undergoing surgery plus radiotherapy had a significantly better 5‐year DFS (74% vs 34%; p = .001) and 5‐year overall survival (OS; 66% vs 27%; p = .003) compared with surgery alone.Conclusion: In patients with metastatic cutaneous HNSCC involving cervical nodes, survival was significantly improved with the addition of radiotherapy. © 2011 Wiley Periodicals, Inc. Head Neck, 2011


  • Patients with clinically node negative extremity Merkel cell carcinoma: The importance of identifying and treating patients with microscopic nodal metastases

    by Michael Veness, Julie Howle

    Objectives:  To review the management of patients with Merkel cell carcinoma (MCC) of the distal arm or leg.Methods:  The files of 27 patients with clinically node‐negative extremity‐located MCC treated between 1993 and 2007 at Westmead Hospital, Sydney, were reviewed.Results:  The median age was 79 (range 48–91 years); there were 16 women and 11 men. The median follow up was 36 months. Eighteen patients had a below knee primary and nine had a below elbow primary. None had previous treatment of draining nodes. Most (26/27) underwent excision and 10 of the 27 received adjuvant local radiotherapy. The median lesion size was 19 mm (range 10–30 mm). In total 55% relapsed with most occurrences in the ipsilateral nodes of the axilla or groin. Median time to relapse was 5.5 months. Overall survival at two and five years was 68% and 57%, respectively.Conclusions:  Patients with extremity MCC experience a high rate of nodal relapse. Recently published evidence supports a survival benefit to identifying patients with microscopic nodal metastases. As en bloc primary and nodal treatment is not possible, and elective nodal treatment is likely to over‐treat many patients, sentinel lymph node biopsy is a useful adjunct to current investigations and should be recommended.


  • POINT OF VIEW: Strategies to successfully publish your first manuscript

    by M Veness

    Applying published evidence is fundamental to the practice of medicine. However, the steps needed to undertake scientific research and generate a manuscript of publishable quality are often overwhelming for junior doctors. Undertaking research and publishing these findings are complementary. Clinicians often present research at college or scientific meetings as oral or poster presentations. Yet despite this, most research is not subsequently submitted for peer review publication in a scientific journal. Reasons put forward for research not being published include lack of time, ongoing study, difficulties with co-authors and a negative study. A lack of experience in the actual process of writing and publishing is also likely to be a contributing factor. The steps required in writing a successful manuscript are multiple and clinicians often lack awareness of the specific formatting requirements for submission to a scientific journal such as JMIRO. The aim of this article is to provide information for clinicians inexperienced in writing and submitting a manuscript with the intent of achieving a publication. It is not meant to be a step-by-step recipe in doing this but a guide as to what is required.


  • Managing patients with cutaneous squamous cell carcinoma metastatic to the axilla or groin lymph nodes

    by Amy Goh, Julie Howle, Michael Hughes, Michael J. Veness

    Cutaneous squamous cell carcinoma accounts for 20% of all non‐melanoma skin cancer with a minority arising on the trunk and extremities. A small proportion will develop metastases to regional nodes of the axilla or groin. We performed a retrospective review of patients with metastatic cutaneous squamous cell carcinoma to the axilla and groin treated at Westmead Hospital, Sydney. The purpose of this study was to document the treatment and outcome of these patients. We identified 18 men and 8 women with a median age of 73 years. Median follow‐up was 18.5 months. Median lesion size was 27 mm (range 3–130 mm) and median thickness was 7 mm (range 3–32 mm). Nine patients developed metastases to the groin, 14 to the axilla, 1 in the epitrochlear, and 2 to both the epitrochlear and axillary lymph nodes. All patients were treated with surgery +/− radiotherapy. Recurrence developed in seven patients (27%) with most developing distant metastases. Most (6/7) patients with recurrence died. Predicting patients that may develop nodal metastatic non‐head and neck cutaneous squamous cell carcinoma is difficult. Following diagnosis, surgery remains the primary treatment and select patients with unfavourable features, such as extranodal spread, may benefit from the addition of adjuvant radiotherapy.


  • Role of definitive radiotherapy in treating patients with inoperable Merkel cell carcinoma: The Westmead Hospital experience and a review of the literature

    by Clare Sl Koh, Michael J Veness

    Merkel cell carcinoma (MCC) is an uncommon aggressive primary cutaneous neuroendocrine carcinoma with a propensity to spread to regional lymph nodes and distant sites. The head and neck is the commonest site for presentation (50–60%) and recent evidence suggests patients treated with excision (to achieve a negative microscopic margin) and adjuvant wide‐field radiotherapy (RTx) have an improved survival compared with surgery alone. Surgery is often not possible in elderly patients with multiple co‐morbidities and in patients with advanced lesions. Definitive RTx therefore remains an option in these inoperable patients, with data to report its benefit. We report the results of eight patients with inoperable MCC treated with RTx alone between 1993 and 2007 at Westmead Hospital, Sydney, Australia, and also review the relevant literature on definitive RTx in the treatment of MCC. The median age at diagnosis was 82.5 years in five women and three men. All patients were Caucasian and none were immunosuppressed. Seven of eight patients were clinically node‐positive. The mean duration of follow up was 12 months. A median dose of 50 Gy was prescribed. Seven of eight patients with inoperable MCC achieved in‐field control, with most eventually relapsing distantly. Treatment‐related toxicity was acceptable. In keeping with our results, other studies also report high rates of in‐field locoregional control following RTx alone. These findings highlight the radioresponsiveness of advanced MCC and support a recommendation of moderate‐dose RTx alone in select cases. Lower‐dose palliative dose fractionation schedules (e.g. 25 Gy in five fractions) may be considered in patients of very poor performance status.


  • Metastatic cutaneous squamous cell carcinoma of the external ear: a high-risk cutaneous subsite

    by S J Turner, G J Morgan, C E Palme, M J Veness

    Introduction: Patients with cutaneous squamous cell carcinoma of the external ear may develop metastatic spread to the nearby ipsilateral parotid and/or upper cervical lymph nodes. The literature suggests that the external ear is a high-risk subsite for such tumours, due to nodal metastasis and its associated morbidity and mortality.Methods: Between 1980 and 2007, 43 patients with a diagnosis of metastatic cutaneous squamous cell carcinoma of the external ear were treated with surgery alone, surgery plus adjuvant radiotherapy, or radiotherapy alone.Results: Patients comprised 39 men and four women. Their median age at diagnosis was 72 years, with a median follow up of 35 months. The median size of the primary lesion was 21 mm, with a median thickness of 7 mm. Fifteen patients presented concurrently with nodal metastases. Thirty patients developed parotid metastases (with positive cervical nodes in six patients), while 13 developed cervical metastases only. Eight patients underwent surgery alone, 32 underwent surgery plus adjuvant radiotherapy, and three received radiotherapy alone. At the last follow up, 15 patients had relapsed and nine had died of their disease, with a median survival after relapse of 5.5 months.Conclusion: Patients with metastatic cutaneous squamous cell carcinoma of the external ear have a relatively poor outcome, with a significant number of patients experiencing nodal relapse and death after treatment.